INSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Inspire Medical Systems Inc (INSP) is not a good buy for a beginner, long-term investor at this time. The stock is facing significant headwinds, including reduced revenue guidance, coding uncertainty, and operational disruptions. Additionally, the lack of positive trading signals, bearish technical indicators, and a neutral sentiment from hedge funds and insiders suggest limited upside potential in the near term.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 59.283, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key resistance levels (R1: 43.887, R2: 45.02) and close to the support level (S1: 40.22). Overall, the technical indicators suggest a bearish trend.
NULL identified. There is no recent news or significant positive developments for the company.
Reduced FY26 revenue guidance with negative growth expected in Q3 and Q
Coding uncertainty and operational disruptions from the WISeR program.
Analysts have significantly lowered price targets, with multiple downgrades to Neutral or Hold ratings.
No recent insider or hedge fund buying activity.
No financial data available for analysis. However, analysts noted a modest Q1 revenue and EPS beat, which was overshadowed by the company's reduced FY26 guidance.
Analysts have broadly downgraded the stock and significantly reduced price targets. The consensus is Neutral, with price targets ranging from $45 to $65, reflecting skepticism about the company's ability to overcome its current challenges.
